These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 16055824)
21. Predictors for starting depot administration of risperidone in chronic users of antipsychotics. Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430 [TBL] [Abstract][Full Text] [Related]
23. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959 [TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotics for the treatment of delirious elders. Ozbolt LB; Paniagua MA; Kaiser RM J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109 [TBL] [Abstract][Full Text] [Related]
26. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics. Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749 [TBL] [Abstract][Full Text] [Related]
27. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857 [TBL] [Abstract][Full Text] [Related]
28. The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia. Chen L; McCombs JS; Park J Value Health; 2008; 11(1):34-43. PubMed ID: 18237358 [TBL] [Abstract][Full Text] [Related]
29. Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. Rossi A; Vita A; Tiradritti P; Romeo F Int Clin Psychopharmacol; 2008 Jul; 23(4):216-22. PubMed ID: 18545060 [TBL] [Abstract][Full Text] [Related]
30. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study. Haro JM; Novick D; Suarez D; Roca M J Psychiatr Res; 2009 Jan; 43(3):265-73. PubMed ID: 18644606 [TBL] [Abstract][Full Text] [Related]
31. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611 [TBL] [Abstract][Full Text] [Related]
32. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897 [TBL] [Abstract][Full Text] [Related]
34. Practice of prescribing antipsychotics in schizophrenia during 2013-2018 based on data from the National Health Fund. Anczewska M; Balicki M; Droździkowska A; Gorczyca P; Janus J; Paciorek S; Plisko R; Zięba M Psychiatr Pol; 2022 Aug; 56(4):751-766. PubMed ID: 37074827 [TBL] [Abstract][Full Text] [Related]
35. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
36. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
37. Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature. Jeste DV; Dolder CR; Nayak GV; Salzman C Harv Rev Psychiatry; 2005; 13(6):340-51. PubMed ID: 16373328 [TBL] [Abstract][Full Text] [Related]
38. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. Kinon BJ; Liu-Seifert H; Adams DH; Citrome L J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821 [TBL] [Abstract][Full Text] [Related]
39. The use of atypical antipsychotics in the treatment of schizophrenia in North Staffordshire. Hodgson R; Belgamwar R; Al-tawarah Y; MacKenzie G Hum Psychopharmacol; 2005 Mar; 20(2):141-7. PubMed ID: 15651052 [TBL] [Abstract][Full Text] [Related]
40. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Hassan M; Madhavan SS; Kalsekar ID; Makela EH; Rajagopalan K; Islam S; Kavookjian J; Miller LA Ann Pharmacother; 2007 Nov; 41(11):1812-8. PubMed ID: 17925501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]